Patient selection key to lowering placebo response rates in lupus clinical trials
From Rheumatology News, 13 June 2023: A major challenge for clinical trials in systemic lupus erythematosus (SLE) is how to get the placebo response rate down low enough that the effectiveness of a drug can actually be seen. Better patient selection may be the key. Speaking at an international congress on SLE, Joan Merrill, MD, … Continue reading Patient selection key to lowering placebo response rates in lupus clinical trials